You are here: Industry Insights > Big Pharma

News List

Continuous Manufacturing Part 1: Advantages to Drug Companies to Approach Continuous Manufacturing Deepak Hegde
March 11, 2021
Learning what are the features attracting big pharma and generic companies to approach Continuous Manufacturing process from Batch Manufacturing process by reading Dr. Deepak Hegde's Continuous Manufacturing series articles.
Novartis to put AveXis into protective custody after data manipulation scandal fiercepharma
September 26, 2019
The Swiss drugmaker says not only will AveXis’ quality team be folded into its organization, it will happen as quickly as possible.
As Bernie predicted, PhRMA, BIO and Big Pharma aired ads during debate programming fiercepharma
August 08, 2019
During the second Democratic 2020 candidate debate last week, Sen. Bernie Sanders predicted healthcare industry ads during CNN commercial breaks. He wasn’t wrong.
Pharmacies take up drug disposal effort Big Pharma has fought fiercepharma
July 20, 2019
Big Pharma has bitterly fought against being forced to pay for drug recycling, but another part of the industry has taken it up: pharmacies.
Who's the next Big Pharma takeout target? Biogen, uniQure, AZ top the list fiercepharma
June 28, 2019
Investors were none too pleased with AbbVie’s planned $63 billion buyout of Allergan, which they made clear by shaving $18 billion off the acquirer’s market cap by the end of the day Tuesday.
China's driving sales growth ahead of the U.S. for Big Pharma. But can it last? fiercepharma
May 29, 2019
If you follow Big Pharma companies’ investor updates, you’ll notice China popping up frequently these days.
Big pharma accused of no action on antibiotic threat europeanpharmaceuticalreview
April 02, 2019
The pharmaceutical industry needs to match words with action on researching new antibiotics to address the threat posed by drug-resistant superbugs…
Big Pharma gave money to patient advocacy groups opposing Medicare changes fiercepharma
March 05, 2019
Dozens of patient advocacy groups, like the Bonnie J. Addario Lung Cancer Foundation and the National Coalition for Cancer Survivorship, recently appeared in national advertisements objecting to a Trump administration proposal that could limit drugs cover
On second thought, Big Pharma CEOs decide to show up at Senate pricing hearings fiercepharma
February 24, 2019
Last week, Sen. Charles Grassley, R-Iowa, vowed to haul pharma CEOs into Senate hearings on drug prices. Now, CEOs for Merck, Pfizer, Sanofi, Bristol-Myers Squibb and AbbVie have heeded the call.
Pharma sales rep regulations proposal stalls in Philadelphia, but the battle's not over yet fiercepharma
January 08, 2019
Big Pharma got a reprieve in Philadelphia last month, but only temporarily. Philadelphia's city council paused its proposal to regulate pharmaceutical sales reps when the bill’s co-sponsors pulled it at the final meeting

Previous page 1 2 Next page